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Introduction
In a rapidly aging population, the prevalence of osteoporosis-related fragility hip fractures (FHFs) is increasing. According to the worldwide projections for FHF, the total number of FHFs in 1990 was estimated to be 1.25 million; this figure is expected to reach approximately 2.6 million by 2025 and 4.5 million by 2050. 1 The incidence is assumed to be the highest in Asia, and the number of patients with FHFs is increasing drastically in Japan. 1, 2 Numerous studies have reported that hip fractures lead to not only decreased ability for daily living and quality of life but also an increased risk of death. [3] [4] [5] [6] [7] [8] [9] [10] Haleem et al. reviewed 36 studies and reported the 1-year mortality rate for FHFs to be as high as 22-29%. 11 Considering that most patients could die due to comorbidities or postoperative complications and not always the fracture itself, it is necessary to identify patients who should receive interventions to reduce their risk of mortality. Various predictive factors have been reported to be associated with an increased risk of mortality, but the relative risk contributions of these factors remain unclear. Hu et al. reviewed 75 studies and identified 12 predictors of mortality with strong evidence. 12 However, the associations between short-term mortality and body mass index (BMI), surgical delay, bone mineral density (BMD) and osteoporosis treatment, length of hospitalization, and patients' acquired activity of daily living (ADL) at discharge remain unclear. In addition, the risk of mortality 1 year after FHF that is associated with reduced BMD at the time of injury remains unclear. 6 Therefore, in this retrospective study, the factors that could predict mortality at 1 year after discharge were identified and evaluated using Kaplan-Meier methods and multivariable Cox proportional hazards models.
Patients and methods

Study design and participants
Five-hundred and seventeen patients aged 60 years or older who were consecutively treated for hip fracture at our 17 affiliated hospitals between March 2013 and March 2016 in the northern Kyushu district of Japan and were followed up to 1 year after discharge were included in this study. The exclusion criteria included patients who suffered from high-energy trauma and pathologic fracture. Patients or their family members were interviewed biannually about the patient's vital status after discharge by a questionnaire or a telephone interview. We defined death after discharge as an endpoint and time from discharge to death was calculated. This study was reviewed and approved by the institutional review board of authors' affiliated institutions. Written informed consent was obtained from all patients before their participation.
Data collection
The following data were collected on admission: sex, age, BMI, total Charlson comorbidity index (TCCI), 13 alcohol consumption (over three units of alcohol per day), smoking,
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Journal of Orthopaedic Surgery 27 (3) BMD, osteoporosis treatment, and previous fractures. We also reviewed the following variables related to hospitalization for FHF: surgical delay, type of fracture and operation, Barthel index (BI) at discharge, length of hospital stay (LOS), and place to discharge. Each variable was categorized as follows. Age was categorized as <75 years, 75 and <85 years, and 85 years. BMI was categorized as BMI <18.5 kg/m 2 , 18.5 BMI <25 kg/m 2 , and BMI 25 kg/m 2 , according to the previous report. 3, 14 For each patient, the number of comorbidities was ascertained from the database and then TCCI was calculated by adding the number of relevant comorbidities with the score derived from the patient's age. 13 We used the median as the cutoff value (TCCI ¼ 4). Lumbar BMD was measured at L2-L4 vertebrae and femoral BMD was measured at the femoral neck of the non-fractured hip. Each BMD data was evaluated based on the young adult mean (YAM) value and categorized as follows: normal, YAM 80%; osteopenia, 70% YAM <80%; and osteoporosis, YAM <70%. When BMD data from the both locations were available and those categories were different, we adopted the worse one as a result of BMD measurement. Osteoporosis treatment was defined as "yes" if a patient had undergone treatment prior to admission. Otherwise, treatment was categorized as "no." Previous fracture was defined as a history of fragility fractures in locations other than the hip. Vertebral fracture, a possible risk factor for mortality by itself, 15 was identified and categorized separately from other two minor variables (none and others). Surgical delay was defined as the interval between the date of injury and the date of surgery. We stratified it every 2 days: delay <2 days, 2 delay <4 days, 4 delay <6 days, and delay 6 days. Type of surgery was categorized as either arthroplasty or internal fixation. BI at discharge was used to assess a patient's basic functional status, in other words, patient's ADL, 16 stratified as BI 70, 30 BI <70, and BI <30, according to the previous report. 5 LOS was defined as the time between admission and discharge from the hospital of initial treatment, stratified as LOS 35 days, 28 LOS <35 days, 14 LOS <28 days, and LOS <14 days, because a patient with hip fracture would be usually treated along a clinical pathway with a standard hospital stay of 2-4 or 5 weeks in Japan. "Place to discharge" refers to residence after discharge and was categorized as home, other medical institution, or others. Especially, "other medical institution" included general hospitals, recovery hospitals, sanatoriums, and clinics.
Statistical analyses
For categorical variables, absolute numbers and relative frequencies were calculated. For continuous variables, means and standard deviations were calculated. For non-normally distributed data, medians and interquartile range were used. Comparison of basic characteristics between male and female patients was conducted, and the difference between two groups was statistically analyzed using Mann-Whitney U test for non-parametric variables or Fisher's exact test for more than two variables, as appropriate ( Table 1) .
The 1-year mortality after discharge was calculated by Kaplan-Meier method. We also plotted the curves for each categorized variable and conducted log-rank test to seek significant association with 1-year mortality. Subsequently, significant variables in the test were introduced into Cox proportional hazards models to evaluate each factor's independent effect on mortality, and the hazard ratios (HRs) with their 95% confidence interval (CI) was estimated. The whole analyses were conducted by sex, because gender bias was considered not to be ignored.
Data were censored at the middle of the follow-up period when a secondary fragility fracture occurred or there was a loss to follow-up. Patients who were alive 1 year after discharge completed the 1-year follow-up period. All analyses were performed using JMP version 13.0. A two-sided p < 0.05 was considered as statistically significant.
Results
We retrospectively identified 517 patients who sustained FHFs in the 3-year period from 2013 to 2016 and they could be followed up until death or 1 year following discharge. Among these patients, 1 patient was excluded from this study due to the refusal to cooperate, and 19 patients were also excluded due to the lack of principal data (date of death: n ¼ 2, BI at discharge: n ¼ 16, BMI on admission: n ¼ 1). As a result, 497 patients who were consecutively treated for FHFs are included in this study.
Patients' data are summarized in Table 1 . The mean age on admission was 82 years, and approximately three times as many patients were women than men. Average BMI was significantly lower in female patients than in male patients (19.8 kg/m 2 vs. 20.5 kg/m 2 , p ¼ 0.042). One or more principal comorbidities were found in 437 patients (87.9%). Among these comorbidities, morbidity of hypertension was significantly higher in female patients than in male patients (50.0% vs. 35.5%, p ¼ 0.009). On the other hand, that of chronic kidney disease was significantly higher in male patients (13.1% vs. 6.9%, p ¼ 0.048), but the value of TCCI was almost same between these two groups. BMD has been measured during hospitalization at lumbar spine in 379 patients and at femoral neck in 451 ones, and both measurements were significantly lower in female patients than in male patients (L-spine: 69.0% vs. 81.5% and femoral neck: 58.0% vs. 62.0%, p < 0.001 and p ¼ 0.037, respectively). As for age, surgical delay, and morbidity of previous fractures, there was no significant difference between two groups.
Except for one patient, all patients were treated surgically. Type of fracture and operation showed the approximately same tendency. Total hip arthroplasty was performed for six intracapsular hip fractures. LOS and BI at discharge were not significantly different.
In total, 45 patients (20 males and 25 females) died within 1 year of discharge, and the total mortality, calculated with the Kaplan-Meier method, was 9.1% (95% CI: 6.8-12.0%, Figure 1 ). The mortality rate was significantly higher in males than in females (19.0% vs. 6.3%, p < 0.001). The results of categorization of each patient's variable with the number of deaths and proportion within each category were described in Table 2 .
The relationships between 1-year mortality and each variable were also elucidated by the methods. Log-rank test revealed that previous fracture (p ¼ 0.003), BI at discharge (p ¼ 0.011), and place to discharge (p ¼ 0.004) were significantly associated with 1-year mortality for male patients. On the other hand, BMI (p ¼ 0.023), TCCI (p ¼ 0.005), smoking (p ¼ 0.007), LOS (p ¼ 0.009), and BI at discharge (p ¼ 0.004) were significant risk of mortality for female patients ( Table 3 ). The final Cox models included the following variables: previous fracture, BI at discharge, and place to discharge for male patients, and BMI, TCCI, smoking, LOS, and BI at discharge for female patients (Table 4 ). In male patients, previous vertebral fractures and BI <30 were significantly higher risk of short-term mortality (HR 3.33 and 5.42, p ¼ 0.044 and 0.013, respectively) compared with the reference group. However, place to discharge was not associated with the mortality. In female patients, BMI <18.5 kg/ m 2 , TCCI 5, and smoking history were found to be the predictive preexisting variables for 1-year mortality (HR 2.70, 2.61, and 3.59, p ¼ 0.023, 0.032, and 0.018, respectively). Astonishingly, the shortest LOS patients' group (LOS <14 days) had as much as 14-focal risk of mortality than the reference one (LOS 35 days, p ¼ 0.007). Also, just like the male patients, BI <30 were the significantly high risk of mortality for female patients (HR 2.76, p ¼ 0.049).
Kaplan-Meier curves of TCCI and LOS for female patients are shown in Figure 2 . Mortality of the female patients whose TCCI was more than 4 at injury was significantly higher than that of the others over an entire study period (Figure 2(a) ). As evidenced in Figure 2 (b), 1-year mortality of LOS <14 days group was the highest than that of any other LOS group in female patients. However, none of the patients of LOS <14 days group died within 2 months from discharge.
Kaplan-Meier curves of BI at discharge for all patients are shown in Figure 3 . Irrespective of gender, the lowest BI group (BI <30) showed a tendency toward increased risk of mortality throughout the study period (Figure 3(a) and (b) ). It was also revealed that BI at discharge significantly increased as the LOS extended only in female patients (Online Supplemental Figure 1 
Discussion
In this retrospective study, aiming to identify predictors of 1-year mortality in FHF patients, previous vertebral fracture and BI <30 were found to be the increased risk of death for male patients. Meanwhile, BMI <18.5 kg/m 2 , TCCI 5, smoking history, LOS <14 days, and BI <30 were the counterparts for female patients. However, other predictors were found not to be associated with death after 1-year followup. We found only BI at discharge to be associated with 1-year mortality for both sexes. LOS and BI at discharge were closely related to each other only in females (Online Supplemental Figure 1 ). Previous studies have shown mixed results on postoperative mortality at 1 year after FHF, ranging from 10.3% 5 to as high as 40%. 10 One-year mortality rate was only 9.1% in the present study, and the mortality in a Japanese population is lower than the ones generally reported in Europe, North America, and South America. 4, 5, 12, 17 It is not clear what these regional differences of the mortality come from, but a recent systematic review reported several mortality predictors including advanced age, male gender, poor activities of daily living, and multiple comorbidities, which were true of our study except for age. 12 Many patients could have died because of their worsened general conditions despite the success of primary treatment. 18 Therefore, preoperative assessment and stabilization should be undertaken rigorously before surgery. 5 TCCI was not so different between males and females, although raised TCCI was an independent risk of mortality for female patients. Preexisting neurological, kidney, respiratory, and gastrointestinal disorders were reported to associate with increased short-term mortality with geriatric hip fractures. 19 TCCI is a sum of all comorbidities combined with the score derived from the patient's age and is reported to be a good preoperative indicator of mortality in elderly patients with hip fractures. 13 If the TCCI was more than 5, 1-year mortality rate was reported to increase linearly with the TCCI. 13 Elderly patients are supposed to have various comorbidities and poor general conditions, so in treating elderly patients with FHFs, not only the fracture but also other comorbidities must be considered. 4 In this study, performance of activities of daily living was assessed using BI 5, 16 and patients with the lowest BI showed a significant high mortality (males: p ¼ 0.013, females: p ¼ 0.049). Considering that the decreased BI reflects deterioration of patient's activities of daily living, its impairment could lead to an increased risk of mortality. Similarly, BI at discharge has been reported to be a significant determinant of mortality risk in a multicenter prospective cohort study involving 33 medical facilities in Japan. 5 In this study, more than half of our deceased patients had a low BMI of 18.5 kg/m 2 or less ( Table 2 ) and that was also an independent and significant risk of death in female patients (p ¼ 0.023). In aforementioned systematic review, decreased BMI, and low serum albumin or malnutrition were found not strong-, but moderate-evidenced predictors of death. 12 Another previous cohort study reported that elderly patients with FHF have a higher rate of malnutrition or are at risk of malnutrition. 20 In this study, average BMI was significantly low in female patients, and deterioration of BMI was one of the independent risks of mortality. Malnutrition and sarcopenia often occur in rehabilitation settings and are associated with poorer rehabilitation outcome and physical function. 21 Sarcopenia is related to worse metabolic and functional health, thus increasing the risk of all-cause mortality. 22 This theory was supported by a study in Japan which reported a high prevalence of sarcopenia and reduced leg muscle mass in patients with sustained FHF. 23 Treatment of nutrition-related sarcopenia requires appropriate nutrition management to improve muscle mass. 21 Taken together, preventing deterioration of ADLs with early interventions such as rehabilitation and appropriate nutritional support might be important for reducing the mortality rate after FHFs. Surprisingly, a shorter duration of hospitalization increased the risk of short-term mortality in female patients. In particular, LOS <14 days was associated with a 14-fold higher risk compared with LOS 35 days. Similarly, a recent observational cohort study of 6143 patients who sustained hip fractures 3 reported that LOS <10 days is an independent risk factor for mortality. The increased risk of death with "LOS <14 days" could suggest the poorly conditioned patients were discharged quickly to other medical institutions, although none of the patient with the shortest LOS group died within 2 months from discharge. Remarkably, BI at discharge significantly increased as the LOS extended in female patients (Online Supplemental Figure 1 ). The median BI of the longest LOS group was almost twice as many as that of the shortest LOS groups (data not shown). We speculate that shorter hospitalization may be associated with fewer adjuvant interventions, such as nutrition and physical training, resulting in unsatisfactory ADL recovery. Short LOS might not be a guarantee of quality and cost-effectiveness if the patients are discharged without acquiring optimized conditions. 3 This study has several limitations. First, although we have analyzed several risk factors, additional information such as original gait pattern, severity of comorbidities, presence of cognitive impairment, and rehabilitation programs after discharge were not available for adjustment. Preoperative patient's disability and physical conditions or postoperative treatment might have affected LOS, place to discharge, and 1-year mortality after sustaining hip fractures. Second, this study did not ascertain the primary and exact cause of death of patients during 1-year follow-up period, since it was hard to access personal information, especially cause of death, via the manual intervention. Third, lack of BMD data could affect the result of univariate analysis (23.8% of BMD at the lumbar spine and 9.3% of BMD at hip could not be measured). However, it is unlikely that only low BMD could directly influence the short-term mortality since fracture itself would have only a marginal effect on total mortality. Finally, potential residual confounding factors related to the observational study design might limit the ability to draw definitive conclusions.
In summary, we performed a multicenter, retrospective study to identify factors that could predict mortality at 1 year after FHFs. Previous vertebral fractures and BI <30 were the predictive variables of mortality for male patients, and BMI <18.5 kg/m 2 , TCCI 5, smoking history, LOS <14 days, and BI <30 were those for females. Decreased BI is one of the independent and preventable risk factors of mortality in both patients group. A comprehensive therapeutic approach should be considered to prevent deterioration of activities of daily living and a higher risk of mortality.
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